WHO updates COVID-19 guidelines: antibiotics advised only with suspected bacterial infection
'This is a strong recommendation for patients with mild COVID-19, and a weaker or conditional one for patients with severe COVID-19,' it noted. The recommendations are based on new evidence as well as changes in the disease's spread and severity.
'Recommendations about the use of antibiotics in COVID-19 patients are based on a recent systematic review and meta-analysis, and the pressing need to address antimicrobial resistance,' said WHO.
The updated guidelines are aimed at people directly or indirectly involved in the healthcare of patients with COVID-19 and post–COVID-19 conditions. This includes clinicians, allied healthcare workers, facility managers, and hospital administrators.
In its note, WHO said that there are two new recommendations about the use of antibiotics which follow from a recent meta-analysis of outcomes in patients treated with antibiotics for COVID-19.
'For patients with non-severe COVID-19 and a low clinical suspicion of a concurrent bacterial infection, we recommend no empirical antibiotics,' it said.
Empirical antibiotics are medications prescribed to treat infections before the specific cause (type of bacteria or other microorganism) is identified. This approach is used when the infection is severe or when waiting for lab results would cause significant harm to patients. Also, WHO added that for patients with severe COVID-19 and a low clinical suspicion of a concurrent bacterial infection, they suggest no empirical antibiotics.
WHO further added that these guidelines have evolved from the first version in 2020 in line with new information and changing circumstances of the pandemic.
'Notable changes to COVID-19 disease over this time have been overall reduced infection rates and reduced disease severity. Emergency measures which were imposed have also been removed, and care for patients with COVID-19 has become more integrated with usual healthcare systems. This different environment has prompted a review of the scope and content of all existing guidance. In order to maintain a clear focus and relevance, we have removed recommendations which would be considered general medical principles, and those which are no longer specific to the management of COVID-19,' it said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
2 hours ago
- The Hindu
Over 7.16 lakh women, children to be administered albendazole tablets in Krishnagiri
Over 7,16,966 women and children will be covered under the deworming campaign scheduled for Monday (August 11, 2025) in Krishnagiri. The National Deworming Day is being observed on August 11 with the intended coverage of 7,16,966 women and children, including 5,52,417 children between the ages of 1 and 19 and 1,64,549 children between the ages of 20 and 30 in the district. The administration, citing the WHO, has stated that Tamil Nadu has about 25% of its population affected by Soil Transmitted Helminth (STH) infections and India contributes 25% to the STH infections globally. The deworming mission envisions coverage of children and teens from the age 1 to 19; and adolescents between 20 to 30 years of age. While 200 mg of tablet albendazole will be given to children between 1 and 2 years of age, 400 mg will be administered to those above 2 years. Pregnant and lactating women will not be given the tablets. STH infections are linked to anaemia, malnutrition, impaired growth, fatigue, loss of appetite, abdominal pain, diarrhoea among other symptoms. The infections are also caused from contamination caused by open defecation. Once STH is addressed through albendazole tablets, the weight of the children will increase, along with cognitive development, and physical stamina. Therefore, District Collector C. Dinesh Kumar has invited public to avail the tablets through the camps. Albendazole tablets will be distributed through 1,796 anganwadi centres, 61 primary health centres, 270 upgraded primary health centres and all schools and colleges. Children who are missed out from coverage will be covered during the second round on August 18.
Indian Express
2 hours ago
- Indian Express
Why US funding cuts on mRNA vaccine research are significant
US Health Secretary Robert F Kennedy Jr has cancelled half a billion dollars in grants and contracts for developing mRNA vaccines, the Department of Health and Human Services said on Tuesday (August 5). A total of 22 contracts with university researchers and private companies to develop new applications for mRNA technology have been terminated. The announcement has dismayed researchers who study infectious diseases, and consider mRNA technology the best option for protecting people during a pandemic. Note that mRNA vaccines helped end the COVID-19 pandemic and saved millions of lives across the world. Here is a look at why Kennedy has cancelled the funding and what the impact of the decision will be. But first, what is mRNA vaccine technology? Vaccines train our immune system to respond to pathogens. For instance, traditional vaccines use inactive or weakened versions of a virus to get the immune system to recognise the virus, and create tools to fight it. mRNA vaccines, on the other hand, give instructions to the body to produce a fragment of a virus, which then kickstarts the immune response. The biggest benefit of mRNA vaccines is that they can be developed within months and quickly altered as the virus changes, unlike traditional vaccines that can take years to develop and test. That's why researchers have been excited about them since they were first deployed to fight against SARS-CoV-2 — the virus that causes COVID-19. Several studies across the world are currently underway to find ways to use this technology to fight other diseases. So why did Kennedy cut the funds? Despite the advantages of mRNA vaccine technology, vaccine sceptics such as Kennedy have long distrusted it. Kennedy once called COVID shots 'the deadliest vaccine ever made'. On Tuesday, he posted a video on X, explaining his decision, and falsely claimed that mRNA vaccines did not protect against respiratory illnesses such as COVID and the flu, and that a single mutation in a virus renders the vaccine ineffective. 'As the pandemic showed us, mRNA vaccines don't perform well against viruses that infect the upper respiratory tract,' he said in the video. Kennedy did not provide any evidence to support his claim. Jennifer Nuzzo, director of the Pandemic Centre at Brown University, told The New York Times, 'By issuing this wildly incorrect statement, the secretary is demonstrating his commitment to his long-held goal of sowing doubts about all vaccines… Had we not used these lifesaving mRNA vaccines to protect against severe illness, we would have had millions of more Covid deaths.' What can be the impact of the decision? Researchers have said that Kennedy's decision would slow down mRNA research, which leaves not only the US but also the whole world more vulnerable to future pandemics. While it is impossible to tell when the next pandemic will occur, there is a consensus among scientists that it will definitely happen, especially in the era of globalisation and human encroachment into new environments. Michael Head, a global health researcher at the University of Southampton, told The Guardian, 'Globalisation and the mixing of people and animals make things more challenging. And so a pandemic will happen at some point. We just don't know when.' The significance of mRNA vaccine technology also goes beyond tackling infectious diseases. For example, US researchers are trying to use the technology to treat cancers such as skin and colon cancers. Researchers are also looking for mRNA vaccines against other diseases, including Lyme disease, dengue fever, and AIDS.
Time of India
4 hours ago
- Time of India
'Thanks to Trump's leadership': US administration targets ‘harmful pandemic-era policies', orders records purge
The Trump administration on Friday ordered all federal agencies to eliminate any records related to workers' COVID-19 vaccination status, noncompliance with pandemic-era mandates, or requests for vaccine exemptions. The rollback of vaccine record retention requirements was announced by the Office of Personnel Management (OPM) in a memo to all federal department and agency heads. OPM explained that the move is in response to recent litigation and is part of the Trump administration's broader effort to reverse 'harmful pandemic-era policies' imposed by former President Joe Biden. 'Things got out of hand during the pandemic, and federal workers were fired, punished, or sidelined for simply making a personal medical decision,' OPM Director Scott Kupor said in a statement. 'That should never have happened.' 'Thanks to President Trump's leadership, we're making sure the excesses of that era do not have lingering effects on federal workers,' Kupor added. Employees can opt out within those 90 days if they wish to keep their COVID vaccine history on file. Agencies must certify compliance with Kupor's order by September 8. In September 2021, Biden signed an executive order forcing all federal workers to take the COVID-19 vaccine as a condition of employment. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Best SIP Plans for NRIs in France – Get ₹2L Monthly Pension | Invest ₹18K PB Learn More Undo A federal judge issued a nationwide injunction blocking the Biden vaccine mandate in January 2022 – by which point the administration said nearly 98% of covered employees had been vaccinated. In April 2022, a three-judge panel on the US Court of Appeals for the Fifth Circuit reversed the injunction, but a year later, the full Fifth Circuit struck down the mandate. Biden rescinded the mandate in May 2023, several months after he declared that the pandemic 'is over' in a September 2022 '60 Minutes' interview.
